cf DNA in maternal blood
- Implementation of non-invasive prenatal testing for aneuploidies in Slovenia

- ‘CPM’ and ‘TFM’: ‘login’ and ‘password’ for decoding cfDNA based testing

- First trimester combined test and cfDNA testing in screening for trisomies 21, 18 and 13

- Estimation of fetal fraction-based risk and redraw success rate in cases that are not callable by NIPT

- The impact of the introduction of cfDNA screening on CVS testing

- First trimester contingent screening for aneuploidies: Proposal of an algorithm

- NIPT present and future

- Сell-free DNA testing in ART pregnancies: pre-test and post-test genetic counseling

- Role of cfDNA testing to reduce the rates of invasive testing and maximise the detection rate

- Non-invasive prenatal tests: impact in portuguese pregnant population

- Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in IVF pregnancies

- Noninvasive prenatal testing: Clinical performance and counselling considerations

- Factors affecting fetal fraction in an Australian population

- Discordant result from NIPT in a phenotypical male fetus with abnormal Y chromosome in 45, X/46, XY mosaic

- Noninvasive prenatal testing (NIPT) for fetal trisomies in a routinely first-trimester screening

- An enhanced SNP-based noninvasive prenatal test reduces the failure rate of detecting aneuploidies

- Clinical experience with a SNP-based noninvasive prenatal test for 22q11. 2 deletion syndrome

- Noninvasive prenatal testing (NIPT): Is It Reliable? A Case report

- NIPT – is it valid for detection of Down's Syndrome caused by Robertsonian translocation?

- Clinical Validation of The IONA® test: A non-invasive prenatal screening test for Trisomy 21, 18 and 13

- Preliminary results of contingent first trimester screening for trisomy 21 with cfDNA analysis in a Danish cohort

- The implementation of NIPT in the first trimester screening for Trisomy 21 in the northern region of Denmark

- Implementation of free fetal DNA testing as second-line screening. Factors affecting the uptake

- Repeated failed non-invasive prenatal testing in a woman with thrombocytopenia and APS

- Positive predictive value of NIPT: Assessment from the diagnostic end at the cytogenetic laboratories

- One clinic’s experience with cell free fetal DNA testing in Argentina

- Increased number of amniocentesis despite growing use of noninvasive tests in R. Macedonia

- Non-invasive prenatal testing for fetal submicroscopic copy number variations by maternal cfDNA sequencing

- First results of fetal chromosome aneuploidy testing using cell-free DNA analysis in Lithuania

- Noninvasive prenatal testing for pregnancies with low risks of fetal aneuploidies in a single center

